Scilex Holding (SCLXW) Cash from Operations (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Cash from Operations of 1100000.0 in Q1 2026, up 106.3% quarter-over-quarter from 17471000.0 in Q4 2025, and down 81.69% on a YoY basis from 6007000.0 in Q1 2025.

Scilex Holding (SCLXW) Cash from Operations (2020 - 2026) Analysis & Trends

Scilex Holding's Cash from Operations history runs 7 years deep, the most recent figure standing at 1100000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations fell 81.69% year-over-year to 1100000.0; the TTM figure through Mar 2026 stood at 1091000.0 (down 106.83% YoY), while the FY2025 annual figure was 3816000.0, down 80.28% from the prior year.
  • Cash from Operations was 1100000.0 for Q1 2026 at Scilex Holding, up from 17471000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 9391000.0 in Q1 2024 to a low of 17471000.0 in Q4 2025.
  • Historically, Cash from Operations has averaged 1041176.47 across 5 years, with a median of 2311000.0 in 2024.
  • Biggest YoY gain for Cash from Operations was 1884.07% in 2022; the steepest drop was 2136.1% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 725000.0 in 2022, then tumbled by 643.45% to 5390000.0 in 2023, then jumped by 147.01% to 2534000.0 in 2024, then plunged by 789.46% to 17471000.0 in 2025, then jumped by 106.3% to 1100000.0 in 2026.
  • The last three Cash from Operations figures came in at 1100000.0 (Q1 2026), 17471000.0 (Q4 2025), and 8187000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 1.82 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.33 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.51 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 3.83 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 3.92 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 2.54 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.62 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.10 Bn
10 Scilex Holding - - 4.15 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.10 Mn
Mar 31, 2026 1.10 Mn
Dec 31, 2025 -17.47 Mn
Dec 31, 2025 -17.47 Mn
Sep 30, 2025 8.19 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 7.09 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 6.01 Mn
Mar 31, 2025 6.01 Mn
Dec 31, 2024 2.53 Mn
Dec 31, 2024 2.53 Mn
Sep 30, 2024 5.11 Mn
Sep 30, 2024 5.11 Mn
Jun 30, 2024 2.31 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 9.39 Mn
Mar 31, 2024 9.39 Mn
Dec 31, 2023 -5.39 Mn
Dec 31, 2023 -5.39 Mn